ArticleESC heart failure2026

Design, rationale, and baseline characteristics of the dapagliflozin in haemodialysis (DAPA-HD) trial.

Thomas A Zelniker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.